KB Home:企業の戦略・SWOT・財務分析

◆英語タイトル:KB Home - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4450
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Construction and Real Estate
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

KB Home – Strategy, SWOT and Corporate Finance Report
Summary

KB Home – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

KB Home is a one of the largest homebuilding provider. The company offers attached and detached single-family residential homes, townhomes and condominiums. It serves first-time, move-up and active adult homebuyers. The company through KB Home Studios offers lot, floor, and exterior plans for design and decor services to the homebuyers. It also offers mortgage assistance, financing, and property and casualty insurance services to the buyers. Since inception, the company has delivered 600,000 in the US. The company has properties across the West Coast, Southwest, Central and Southeast regions of the US. KB Home is headquartered in Los Angeles, California, the US.

Scope

- Detailed information on KB Home required for business and competitor intelligence needs
- A study of the major internal and external factors affecting KB Home in the form of a SWOT analysis
- An in-depth view of the business model of KB Home including a breakdown and examination of key business segments
- Intelligence on KB Home’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about KB Home, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of KB Home and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess KB Home as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on KB Home’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
KB Home: Company Overview
KB Home: Overview and Key Facts
KB Home: Overview
KB Home: Key Facts
KB Home: Key Employees
KB Home: Key Employee Biographies
KB Home: Major Products and Services
KB Home: Company History
KB Home: Management Statement
KB Home: Locations and Subsidiaries
KB Home: Key Competitors
KB Home: Company Analysis
KB Home: Business Description
KB Home: SWOT Analysis
KB Home: SWOT Overview
KB Home: Strengths
KB Home: Weaknesses
KB Home: Opportunities
KB Home: Threats
KB Home: Corporate Financial Deals Activity
KB Home: Financial Deals Overview
KB Home: Top Deals 2016 – 2020YTD*
KB Home: Advisors
KB Home: Top Legal Advisors
KB Home: Top Financial Advisors
KB Home: Capital Raising
KB Home: Recent Developments
KB Home: News and Events Summary
KB Home: Business Expansion
KB Home: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: KB Home: Key Facts
Table 2: KB Home: Key Employees
Table 3: KB Home: Company History
Table 4: KB Home: Locations and Subsidiaries
Table 5: KB Home: Key Competitors
Table 6: KB Home: Deal Activity by Deal Type - Volume (TTM*)
Table 7: KB Home: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: KB Home: Top Deals 2016 - 2020YTD*
Table 9: KB Home: Legal Advisor Ranking by Value (US$m)
Table 10: KB Home: Financial Advisor Ranking by Value (US$m)
Table 11: KB Home: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: KB Home: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: KB Home: News and Events Summary
Table 14: KB Home: Business Expansion
Table 15: KB Home: Strategy and Operations

★海外企業調査レポート[KB Home:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Westar Energy Inc:企業の発電所・SWOT分析2018
    Westar Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Momenta Pharmaceuticals Inc (MNTA):企業の財務・戦略的SWOT分析
    Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • OGD2 Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary OGD2 Pharma SAS (OGD2 Pharma) is an independent pre-clinical stage biotechnology company that researches, develops and commercializes cancer immunotherapies targeting the O-acetylated form of the GD2 ganglioside (OAcGD2). The company pipeline product portfolio includes OGD201, a humanized mo …
  • Diversicare Healthcare Services Inc (DVCR):企業の財務・戦略的SWOT分析
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • GEDI Gruppo Editoriale SpA (GEDI):企業の財務・戦略的SWOT分析
    GEDI Gruppo Editoriale SpA (GEDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kering SA:企業のM&A・事業提携・投資動向
    Kering SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kering SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • TauRx Pharmaceuticals Ltd:医療機器:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Trident Limited:戦略・SWOT・企業財務分析
    Trident Limited - Strategy, SWOT and Corporate Finance Report Summary Trident Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Classic Cosmetics, Inc:企業の戦略・SWOT・財務情報
    Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report Summary Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Foxconn Technology Co Ltd:企業の戦略・SWOT・財務分析
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆